ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Regenerative Medicine Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-27W15743
Home | Market Reports | Health| Nursing
Global and India Regenerative Medicine Market Report Forecast 2023 2029
BUY CHAPTERS

Global Regenerative Medicine Market Report & Forecast 2023-2029

Code: QYRE-Auto-27W15743
Report
November 2023
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
J &J (DePuy Synthes)
Medtronic Inc
Zimmer Biomet
Stryker
Allergan(Acelity)
MiMedx Group
Organogenesis Inc
Fujifilm Cellular Dynamics
Osiris Therapeutics
Vcanbio
CCBC
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast Limited
AMAG Pharmaceuticals (CBR)
ViaCord
CordLife
Integra LifeSciences
NuVasive
Cook Biotech
Japan Tissue Engineering

Regenerative Medicine Market Size

The global Regenerative Medicine revenue was US$ 33370 million in 2022 and is forecast to a readjusted size of US$ 115660 million by 2029 with a CAGR of 19.2% during the review period (2023-2029).

and India Regenerative Medicine Market

Regenerative Medicine Market

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.
Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and “the vanguard of 21st century healthcare” by the U.S. Department of Health and Human Services.
 
In India, the Regenerative Medicine revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.
Global Regenerative Medicine key players include J & J (DePuy Synthes), Medtronic, Allergan(Acelity), Zimmer Biomet, etc. Global top four manufacturers hold a share about 10%.
North America is the largest market, with a share about 25%, followed by Europe, and Asia Pacific, both have a share over 40 percent.
In terms of product, Tissue Engineering is the largest segment, with a share over 40%. And in terms of application, the largest application is Dermatology, followed by Cardiovascular, CNS, Orthopedic, etc.
This report focuses on global Regenerative Medicine market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Regenerative Medicine will continue to grow rapidly in the future.
Global Regenerative Medicine Scope and Market Size
Regenerative Medicine market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Regenerative Medicine market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.
 

Scope of Regenerative Medicine Market Report

Report Metric Details
Report Name Regenerative Medicine Market
Forecasted market size in 2029 US$ 115660 million
CAGR 19.2%
Forecasted years 2023 - 2029
Segment by Type
  • Cell Therapy
  • Tissue Engineering
  • Biomaterial
  • Other
Segment by Application
  • Dermatology
  • Cardiovascular
  • CNS
  • Orthopedic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company J & J (DePuy Synthes), Medtronic, Zimmer Biomet, Stryker, Allergan(Acelity), MiMedx Group, Organogenesis, Fujifilm Cellular Dynamics, Osiris Therapeutics, Vcanbio, CCBC, Cytori, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, AMAG Pharmaceuticals (CBR), ViaCord, CordLife, Integra LifeSciences, Nuvasive, Cook Biotech, Japan Tissue Engineering
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the Regenerative Medicine Market size in 2029?

Ans: The Regenerative Medicine Market size in 2029 will be US$ 115660 million.

What is the market share of major companies in Regenerative Medicine Market?

Ans: Global top four manufacturers hold a share about 10%.

What is the Regenerative Medicine Market share by type?

Ans: In terms of product, Tissue Engineering is the largest segment, with a share over 40%.

What is the Regenerative Medicine Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the Regenerative Medicine Market report?

Ans: The main players in the Regenerative Medicine Market are J & J (DePuy Synthes), Medtronic, Zimmer Biomet, Stryker, Allergan(Acelity), MiMedx Group, Organogenesis, Fujifilm Cellular Dynamics, Osiris Therapeutics, Vcanbio, CCBC, Cytori, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, AMAG Pharmaceuticals (CBR), ViaCord, CordLife, Integra LifeSciences, Nuvasive, Cook Biotech, Japan Tissue Engineering

What are the Application segmentation covered in the Regenerative Medicine Market report?

Ans: The Applications covered in the Regenerative Medicine Market report are Dermatology, Cardiovascular, CNS, Orthopedic, Others

What are the Type segmentation covered in the Regenerative Medicine Market report?

Ans: The Types covered in the Regenerative Medicine Market report are Cell Therapy, Tissue Engineering, Biomaterial, Other

1 Study Coverage
1.1 Regenerative Medicine Product Introduction
1.2 Global Regenerative Medicine Outlook 2018 VS 2022 VS 2029
1.2.1 Global Regenerative Medicine Market Size for the Year 2018-2029
1.2.2 India Regenerative Medicine Market Size for the Year 2018-2029
1.3 Regenerative Medicine Market Size, India VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of India Regenerative Medicine in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of Regenerative Medicine Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4 Regenerative Medicine Market Dynamics
1.4.1 Regenerative Medicine Industry Trends
1.4.2 Regenerative Medicine Market Drivers
1.4.3 Regenerative Medicine Market Challenges
1.4.4 Regenerative Medicine Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Regenerative Medicine by Type
2.1 Regenerative Medicine Market Segment by Type
2.1.1 Cell Therapy
2.1.2 Tissue Engineering
2.1.3 Biomaterial
2.1.4 Other
2.2 Global Regenerative Medicine Market Size by Type (2018, 2022 & 2029)
2.3 Global Regenerative Medicine Market Size by Type (2018-2029)
2.4 India Regenerative Medicine Market Size by Type (2018, 2022 & 2029)
2.5 India Regenerative Medicine Market Size by Type (2018-2029)
3 Regenerative Medicine by Application
3.1 Regenerative Medicine Market Segment by Application
3.1.1 Dermatology
3.1.2 Cardiovascular
3.1.3 CNS
3.1.4 Orthopedic
3.1.5 Others
3.2 Global Regenerative Medicine Market Size by Application (2018, 2022 & 2029)
3.3 Global Regenerative Medicine Market Size by Application (2018-2029)
3.4 India Regenerative Medicine Market Size by Application (2018, 2022 & 2029)
3.5 India Regenerative Medicine Market Size by Application (2018-2029)
4 Global Regenerative Medicine Competitor Landscape by Company
4.1 Global Regenerative Medicine Market Size by Company
4.1.1 Global Key Companies of Regenerative Medicine, Ranked by Revenue (2022)
4.1.2 Global Regenerative Medicine Revenue by Player (2018-2023)
4.2 Global Regenerative Medicine Concentration Ratio (CR)
4.2.1 Regenerative Medicine Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Regenerative Medicine in 2022
4.2.3 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Regenerative Medicine Head office and Area Served
4.4 Global Key Players of Regenerative Medicine, Product and Application
4.5 Global Key Players of Regenerative Medicine, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Regenerative Medicine Market Size by Company
4.7.1 Key Players of Regenerative Medicine in India, Ranked by Revenue (2022)
4.7.2 India Regenerative Medicine Revenue by Players (2021, 2022 & 2023)
5 Global Regenerative Medicine Market Size by Region
5.1 Global Regenerative Medicine Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Regenerative Medicine Market Size by Region (2018-2029)
5.2.1 Global Regenerative Medicine Market Size by Region: 2018-2023
5.2.2 Global Regenerative Medicine Market Size by Region (2024-2029)
6 Americas
6.1 Americas Regenerative Medicine Market Size YoY Growth 2018-2029
6.2 Americas Regenerative Medicine Market Size by Type
6.2.1 Americas Regenerative Medicine Market Size by Type (2018-2023)
6.2.2 Americas Regenerative Medicine Market Size by Type (2024-2029)
6.2.3 Americas Regenerative Medicine Market Share by Type (2018-2029)
6.3 Americas Regenerative Medicine Market Size by Application
6.3.1 Americas Regenerative Medicine Market Size by Application (2018-2023)
6.3.2 Americas Regenerative Medicine Market Size by Application (2024-2029)
6.3.3 Americas Regenerative Medicine Market Share by Application (2018-2029)
6.4 Americas Regenerative Medicine Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Regenerative Medicine Market Size YoY Growth 2018-2029
7.2 EMEA Regenerative Medicine Market Size by Type
7.2.1 EMEA Regenerative Medicine Market Size by Type (2018-2023)
7.2.2 EMEA Regenerative Medicine Market Size by Type (2024-2029)
7.2.3 EMEA Regenerative Medicine Market Share by Type (2018-2029)
7.3 EMEA Regenerative Medicine Market Size by Application
7.3.1 EMEA Regenerative Medicine Market Size by Application (2018-2023)
7.3.2 EMEA Regenerative Medicine Market Size by Application (2024-2029)
7.3.3 EMEA Regenerative Medicine Market Share by Application (2018-2029)
7.4 EMEA Regenerative Medicine Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Regenerative Medicine Market Size YoY Growth 2018-2029
8.2 China Regenerative Medicine Market Size by Type
8.2.1 China Regenerative Medicine Market Size by Type (2018-2023)
8.2.2 China Regenerative Medicine Market Size by Type (2024-2029)
8.2.3 China Regenerative Medicine Market Share by Type (2018-2029)
8.3 China Regenerative Medicine Market Size by Application
8.3.1 China Regenerative Medicine Market Size by Application (2018-2023)
8.3.2 China Regenerative Medicine Market Size by Application (2024-2029)
8.3.3 China Regenerative Medicine Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Regenerative Medicine Market Size YoY Growth 2018-2029
9.2 APAC Regenerative Medicine Market Size by Type
9.2.1 APAC Regenerative Medicine Market Size by Type (2018-2023)
9.2.2 APAC Regenerative Medicine Market Size by Type (2024-2029)
9.2.3 APAC Regenerative Medicine Market Share by Type (2018-2029)
9.3 APAC Regenerative Medicine Market Size by Application
9.3.1 APAC Regenerative Medicine Market Size by Application (2018-2023)
9.3.2 APAC Regenerative Medicine Market Size by Application (2024-2029)
9.3.3 APAC Regenerative Medicine Market Share by Application (2018-2029)
9.4 APAC Regenerative Medicine Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 J & J (DePuy Synthes)
10.1.1 J & J (DePuy Synthes) Company Details
10.1.2 J & J (DePuy Synthes) Business Overview
10.1.3 J & J (DePuy Synthes) Regenerative Medicine Introduction
10.1.4 J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2018-2023)
10.1.5 J & J (DePuy Synthes) Recent Development
10.2 Medtronic
10.2.1 Medtronic Company Details
10.2.2 Medtronic Business Overview
10.2.3 Medtronic Regenerative Medicine Introduction
10.2.4 Medtronic Revenue in Regenerative Medicine Business (2018-2023)
10.2.5 Medtronic Recent Development
10.3 Zimmer Biomet
10.3.1 Zimmer Biomet Company Details
10.3.2 Zimmer Biomet Business Overview
10.3.3 Zimmer Biomet Regenerative Medicine Introduction
10.3.4 Zimmer Biomet Revenue in Regenerative Medicine Business (2018-2023)
10.3.5 Zimmer Biomet Recent Development
10.4 Stryker
10.4.1 Stryker Company Details
10.4.2 Stryker Business Overview
10.4.3 Stryker Regenerative Medicine Introduction
10.4.4 Stryker Revenue in Regenerative Medicine Business (2018-2023)
10.4.5 Stryker Recent Development
10.5 Allergan(Acelity)
10.5.1 Allergan(Acelity) Company Details
10.5.2 Allergan(Acelity) Business Overview
10.5.3 Allergan(Acelity) Regenerative Medicine Introduction
10.5.4 Allergan(Acelity) Revenue in Regenerative Medicine Business (2018-2023)
10.5.5 Allergan(Acelity) Recent Development
10.6 MiMedx Group
10.6.1 MiMedx Group Company Details
10.6.2 MiMedx Group Business Overview
10.6.3 MiMedx Group Regenerative Medicine Introduction
10.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2018-2023)
10.6.5 MiMedx Group Recent Development
10.7 Organogenesis
10.7.1 Organogenesis Company Details
10.7.2 Organogenesis Business Overview
10.7.3 Organogenesis Regenerative Medicine Introduction
10.7.4 Organogenesis Revenue in Regenerative Medicine Business (2018-2023)
10.7.5 Organogenesis Recent Development
10.8 Fujifilm Cellular Dynamics
10.8.1 Fujifilm Cellular Dynamics Company Details
10.8.2 Fujifilm Cellular Dynamics Business Overview
10.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Introduction
10.8.4 Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2018-2023)
10.8.5 Fujifilm Cellular Dynamics Recent Development
10.9 Osiris Therapeutics
10.9.1 Osiris Therapeutics Company Details
10.9.2 Osiris Therapeutics Business Overview
10.9.3 Osiris Therapeutics Regenerative Medicine Introduction
10.9.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2018-2023)
10.9.5 Osiris Therapeutics Recent Development
10.10 Vcanbio
10.10.1 Vcanbio Company Details
10.10.2 Vcanbio Business Overview
10.10.3 Vcanbio Regenerative Medicine Introduction
10.10.4 Vcanbio Revenue in Regenerative Medicine Business (2018-2023)
10.10.5 Vcanbio Recent Development
10.11 CCBC
10.11.1 CCBC Company Details
10.11.2 CCBC Business Overview
10.11.3 CCBC Regenerative Medicine Introduction
10.11.4 CCBC Revenue in Regenerative Medicine Business (2018-2023)
10.11.5 CCBC Recent Development
10.12 Cytori
10.12.1 Cytori Company Details
10.12.2 Cytori Business Overview
10.12.3 Cytori Regenerative Medicine Introduction
10.12.4 Cytori Revenue in Regenerative Medicine Business (2018-2023)
10.12.5 Cytori Recent Development
10.13 Celgene
10.13.1 Celgene Company Details
10.13.2 Celgene Business Overview
10.13.3 Celgene Regenerative Medicine Introduction
10.13.4 Celgene Revenue in Regenerative Medicine Business (2018-2023)
10.13.5 Celgene Recent Development
10.14 Vericel Corporation
10.14.1 Vericel Corporation Company Details
10.14.2 Vericel Corporation Business Overview
10.14.3 Vericel Corporation Regenerative Medicine Introduction
10.14.4 Vericel Corporation Revenue in Regenerative Medicine Business (2018-2023)
10.14.5 Vericel Corporation Recent Development
10.15 Guanhao Biotech
10.15.1 Guanhao Biotech Company Details
10.15.2 Guanhao Biotech Business Overview
10.15.3 Guanhao Biotech Regenerative Medicine Introduction
10.15.4 Guanhao Biotech Revenue in Regenerative Medicine Business (2018-2023)
10.15.5 Guanhao Biotech Recent Development
10.16 Mesoblast
10.16.1 Mesoblast Company Details
10.16.2 Mesoblast Business Overview
10.16.3 Mesoblast Regenerative Medicine Introduction
10.16.4 Mesoblast Revenue in Regenerative Medicine Business (2018-2023)
10.16.5 Mesoblast Recent Development
10.17 AMAG Pharmaceuticals (CBR)
10.17.1 AMAG Pharmaceuticals (CBR) Company Details
10.17.2 AMAG Pharmaceuticals (CBR) Business Overview
10.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Introduction
10.17.4 AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2018-2023)
10.17.5 AMAG Pharmaceuticals (CBR) Recent Development
10.18 ViaCord
10.18.1 ViaCord Company Details
10.18.2 ViaCord Business Overview
10.18.3 ViaCord Regenerative Medicine Introduction
10.18.4 ViaCord Revenue in Regenerative Medicine Business (2018-2023)
10.18.5 ViaCord Recent Development
10.19 CordLife
10.19.1 CordLife Company Details
10.19.2 CordLife Business Overview
10.19.3 CordLife Regenerative Medicine Introduction
10.19.4 CordLife Revenue in Regenerative Medicine Business (2018-2023)
10.19.5 CordLife Recent Development
10.20 Integra LifeSciences
10.20.1 Integra LifeSciences Company Details
10.20.2 Integra LifeSciences Business Overview
10.20.3 Integra LifeSciences Regenerative Medicine Introduction
10.20.4 Integra LifeSciences Revenue in Regenerative Medicine Business (2018-2023)
10.20.5 Integra LifeSciences Recent Development
10.21 Nuvasive
10.21.1 Nuvasive Company Details
10.21.2 Nuvasive Business Overview
10.21.3 Nuvasive Regenerative Medicine Introduction
10.21.4 Nuvasive Revenue in Regenerative Medicine Business (2018-2023)
10.21.5 Nuvasive Recent Development
10.22 Cook Biotech
10.22.1 Cook Biotech Company Details
10.22.2 Cook Biotech Business Overview
10.22.3 Cook Biotech Regenerative Medicine Introduction
10.22.4 Cook Biotech Revenue in Regenerative Medicine Business (2018-2023)
10.22.5 Cook Biotech Recent Development
10.23 Japan Tissue Engineering
10.23.1 Japan Tissue Engineering Company Details
10.23.2 Japan Tissue Engineering Business Overview
10.23.3 Japan Tissue Engineering Regenerative Medicine Introduction
10.23.4 Japan Tissue Engineering Revenue in Regenerative Medicine Business (2018-2023)
10.23.5 Japan Tissue Engineering Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
FEATURED COMPANIES
J &J (DePuy Synthes)
Medtronic Inc
Zimmer Biomet
Stryker
Allergan(Acelity)
MiMedx Group
Organogenesis Inc
Fujifilm Cellular Dynamics
Osiris Therapeutics
Vcanbio
CCBC
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast Limited
AMAG Pharmaceuticals (CBR)
ViaCord
CordLife
Integra LifeSciences
NuVasive
Cook Biotech
Japan Tissue Engineering
List of Tables
    Table 1. Regenerative Medicine Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)
    Table 2. Regenerative Medicine Market Trends
    Table 3. Regenerative Medicine Market Drivers
    Table 4. Regenerative Medicine Market Challenges
    Table 5. Regenerative Medicine Market Restraints
    Table 6. Global Regenerative Medicine Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Regenerative Medicine Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Regenerative Medicine Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Regenerative Medicine Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Companies of Regenerative Medicine, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Regenerative Medicine Revenue by Player, (US$ Million), 2018-2023
    Table 12. Global Regenerative Medicine Revenue Share by Player, 2018-2023
    Table 13. Global Regenerative Medicine Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Regenerative Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2022)
    Table 15. Global Key Players of Regenerative Medicine, Headquarters and Area Served
    Table 16. Global Key Players of Regenerative Medicine, Product and Application
    Table 17. Global Key Players of Regenerative Medicine, Date of Enter into This Industry
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Key Players of Regenerative Medicine in India, Ranked by Revenue (2022) & (US$ Million)
    Table 20. India Regenerative Medicine Revenue by Players, (US$ Million), 2021, 2022 & 2023
    Table 21. India Regenerative Medicine Revenue Share by Players, 2021, 2022 & 2023
    Table 22. Global Regenerative Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 23. Global Regenerative Medicine Market Size by Region (2018-2023) & (US$ Million)
    Table 24. Global Regenerative Medicine Market Size Forecast by Region (2024-2029) & (US$ Million)
    Table 25. Americas Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Americas Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Americas Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Americas Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
    Table 29. Americas Regenerative Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 30. Americas Regenerative Medicine Market Size by Country (2018-2023) & (US$ Million)
    Table 31. Americas Regenerative Medicine Market Size by Country (2024-2029) & (US$ Million)
    Table 32. EMEA Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
    Table 33. EMEA Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
    Table 34. EMEA Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
    Table 35. EMEA Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
    Table 36. EMEA Regenerative Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. EMEA Regenerative Medicine Market Size by Country (2018-2023) & (US$ Million)
    Table 38. EMEA Regenerative Medicine Market Size by Country (2024-2029) & (US$ Million)
    Table 39. China Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
    Table 40. China Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
    Table 41. China Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
    Table 42. China Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
    Table 43. China Regenerative Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. APAC Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
    Table 45. APAC Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
    Table 46. APAC Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
    Table 47. APAC Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
    Table 48. APAC Regenerative Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 49. APAC Regenerative Medicine Market Size by Region (2018-2023) & (US$ Million)
    Table 50. APAC Regenerative Medicine Market Size by Region (2024-2029) & (US$ Million)
    Table 51. J & J (DePuy Synthes) Company Details
    Table 52. J & J (DePuy Synthes) Business Overview
    Table 53. J & J (DePuy Synthes) Regenerative Medicine Product
    Table 54. J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 55. J & J (DePuy Synthes) Recent Development
    Table 56. Medtronic Company Details
    Table 57. Medtronic Business Overview
    Table 58. Medtronic Regenerative Medicine Product
    Table 59. Medtronic Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 60. Medtronic Recent Development
    Table 61. Zimmer Biomet Company Details
    Table 62. Zimmer Biomet Business Overview
    Table 63. Zimmer Biomet Regenerative Medicine Product
    Table 64. Zimmer Biomet Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 65. Zimmer Biomet Recent Development
    Table 66. Stryker Company Details
    Table 67. Stryker Business Overview
    Table 68. Stryker Regenerative Medicine Product
    Table 69. Stryker Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 70. Stryker Recent Development
    Table 71. Allergan(Acelity) Company Details
    Table 72. Allergan(Acelity) Business Overview
    Table 73. Allergan(Acelity) Regenerative Medicine Product
    Table 74. Allergan(Acelity) Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 75. Allergan(Acelity) Recent Development
    Table 76. MiMedx Group Company Details
    Table 77. MiMedx Group Business Overview
    Table 78. MiMedx Group Regenerative Medicine Product
    Table 79. MiMedx Group Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 80. MiMedx Group Recent Development
    Table 81. Organogenesis Company Details
    Table 82. Organogenesis Business Overview
    Table 83. Organogenesis Regenerative Medicine Product
    Table 84. Organogenesis Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 85. Organogenesis Recent Development
    Table 86. Fujifilm Cellular Dynamics Company Details
    Table 87. Fujifilm Cellular Dynamics Business Overview
    Table 88. Fujifilm Cellular Dynamics Regenerative Medicine Product
    Table 89. Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 90. Fujifilm Cellular Dynamics Recent Development
    Table 91. Osiris Therapeutics Company Details
    Table 92. Osiris Therapeutics Business Overview
    Table 93. Osiris Therapeutics Regenerative Medicine Product
    Table 94. Osiris Therapeutics Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 95. Osiris Therapeutics Recent Development
    Table 96. Vcanbio Company Details
    Table 97. Vcanbio Business Overview
    Table 98. Vcanbio Regenerative Medicine Product
    Table 99. Vcanbio Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 100. Vcanbio Recent Development
    Table 101. CCBC Company Details
    Table 102. CCBC Business Overview
    Table 103. CCBC Regenerative Medicine Product
    Table 104. CCBC Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 105. CCBC Recent Development
    Table 106. Cytori Company Details
    Table 107. Cytori Business Overview
    Table 108. Cytori Regenerative Medicine Product
    Table 109. Cytori Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 110. Cytori Recent Development
    Table 111. Celgene Company Details
    Table 112. Celgene Business Overview
    Table 113. Celgene Regenerative Medicine Product
    Table 114. Celgene Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 115. Celgene Recent Development
    Table 116. Vericel Corporation Company Details
    Table 117. Vericel Corporation Business Overview
    Table 118. Vericel Corporation Regenerative Medicine Product
    Table 119. Vericel Corporation Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 120. Vericel Corporation Recent Development
    Table 121. Guanhao Biotech Company Details
    Table 122. Guanhao Biotech Business Overview
    Table 123. Guanhao Biotech Regenerative Medicine Product
    Table 124. Guanhao Biotech Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 125. Guanhao Biotech Recent Development
    Table 126. Mesoblast Company Details
    Table 127. Mesoblast Business Overview
    Table 128. Mesoblast Regenerative Medicine Product
    Table 129. Mesoblast Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 130. Mesoblast Recent Development
    Table 131. AMAG Pharmaceuticals (CBR) Company Details
    Table 132. AMAG Pharmaceuticals (CBR) Business Overview
    Table 133. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product
    Table 134. AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 135. AMAG Pharmaceuticals (CBR) Recent Development
    Table 136. ViaCord Company Details
    Table 137. ViaCord Business Overview
    Table 138. ViaCord Regenerative Medicine Product
    Table 139. ViaCord Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 140. ViaCord Recent Development
    Table 141. CordLife Company Details
    Table 142. CordLife Business Overview
    Table 143. CordLife Regenerative Medicine Product
    Table 144. CordLife Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 145. CordLife Recent Development
    Table 146. Integra LifeSciences Company Details
    Table 147. Integra LifeSciences Business Overview
    Table 148. Integra LifeSciences Regenerative Medicine Product
    Table 149. Integra LifeSciences Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 150. Integra LifeSciences Recent Development
    Table 151. Nuvasive Company Details
    Table 152. Nuvasive Business Overview
    Table 153. Nuvasive Regenerative Medicine Product
    Table 154. Nuvasive Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 155. Nuvasive Recent Development
    Table 156. Cook Biotech Company Details
    Table 157. Cook Biotech Business Overview
    Table 158. Cook Biotech Regenerative Medicine Product
    Table 159. Cook Biotech Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 160. Cook Biotech Recent Development
    Table 161. Japan Tissue Engineering Company Details
    Table 162. Japan Tissue Engineering Business Overview
    Table 163. Japan Tissue Engineering Regenerative Medicine Product
    Table 164. Japan Tissue Engineering Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 165. Japan Tissue Engineering Recent Development
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Regenerative Medicine Product Picture
    Figure 2. Global Regenerative Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Regenerative Medicine Market Size 2018-2029 (US$ Million)
    Figure 4. India Regenerative Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 5. India Regenerative Medicine Market Size 2018-2029 (US$ Million)
    Figure 6. India Regenerative Medicine Market Share in Global 2018-2029
    Figure 7. Regenerative Medicine Report Years Considered
    Figure 8. Product Picture of Cell Therapy
    Figure 9. Product Picture of Tissue Engineering
    Figure 10. Product Picture of Biomaterial
    Figure 11. Product Picture of Other
    Figure 12. Global Regenerative Medicine Market Share by Type in 2022 & 2029
    Figure 13. Global Regenerative Medicine Market Size by Type (2018-2029) & (US$ Million)
    Figure 14. Global Regenerative Medicine Market Share by Type (2018-2029)
    Figure 15. India Regenerative Medicine Market Share by Type in 2022 & 2029
    Figure 16. India Regenerative Medicine Market Size by Type (2018-2029) & (US$ Million)
    Figure 17. India Regenerative Medicine Market Share by Type (2018-2029)
    Figure 18. Product Picture of Dermatology
    Figure 19. Product Picture of Cardiovascular
    Figure 20. Product Picture of CNS
    Figure 21. Product Picture of Orthopedic
    Figure 22. Product Picture of Others
    Figure 23. Global Regenerative Medicine Market Share by Application in 2022 & 2029
    Figure 24. Global Regenerative Medicine Market Size by Application (2018-2029) & (US$ Million)
    Figure 25. Global Regenerative Medicine Market Share by Application (2018-2029)
    Figure 26. India Regenerative Medicine Market Share by Application in 2022 & 2029
    Figure 27. India Regenerative Medicine Market Size by Application (2018-2029) & (US$ Million)
    Figure 28. India Regenerative Medicine Market Share by Application (2018-2029)
    Figure 29. The Top 5 and 10 Largest Companies of Regenerative Medicine in the World: Market Share by Regenerative Medicine Revenue in 2022
    Figure 30. Global Regenerative Medicine Market Size Market Share by Region: 2018 VS 2022 VS 2029
    Figure 31. Global Regenerative Medicine Market Share by Region (2018-2029)
    Figure 32. Americas Regenerative Medicine Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 33. Americas Regenerative Medicine Market Share by Type (2018-2029)
    Figure 34. Americas Regenerative Medicine Market Share by Application (2018-2029)
    Figure 35. United States Regenerative Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Canada Regenerative Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Mexico Regenerative Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Brazil Regenerative Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 39. EMEA Regenerative Medicine Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 40. EMEA Regenerative Medicine Market Share by Type (2018-2029)
    Figure 41. EMEA Regenerative Medicine Market Share by Application (2018-2029)
    Figure 42. Europe Regenerative Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Middle East Regenerative Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Africa Regenerative Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 45. China Regenerative Medicine Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 46. China Regenerative Medicine Market Share by Type (2018-2029)
    Figure 47. China Regenerative Medicine Market Share by Application (2018-2029)
    Figure 48. APAC Regenerative Medicine Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 49. APAC Regenerative Medicine Market Share by Type (2018-2029)
    Figure 50. APAC Regenerative Medicine Market Share by Application (2018-2029)
    Figure 51. Japan Regenerative Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 52. South Korea Regenerative Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 53. China Taiwan Regenerative Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Southeast Asia Regenerative Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 55. India Regenerative Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 56. J & J (DePuy Synthes) Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 57. Medtronic Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 58. Zimmer Biomet Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 59. Stryker Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 60. Allergan(Acelity) Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 61. MiMedx Group Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 62. Organogenesis Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 63. Fujifilm Cellular Dynamics Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 64. Osiris Therapeutics Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 65. Vcanbio Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 66. CCBC Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 67. Cytori Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 68. Celgene Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 69. Vericel Corporation Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 70. Guanhao Biotech Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 71. Mesoblast Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 72. AMAG Pharmaceuticals (CBR) Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 73. ViaCord Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 74. CordLife Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 75. Integra LifeSciences Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 76. Nuvasive Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 77. Cook Biotech Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 78. Japan Tissue Engineering Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global MRO Data Cleansing and Enrichment Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-39V17668
Mon Oct 13 00:00:00 UTC 2025

Add to Cart

Global Lipidomics Analysis Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-22L19757
Mon Oct 06 00:00:00 UTC 2025

Add to Cart

Global Spatial Transcriptomics Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-29Y19622
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Internet Intelligent Elderly Care Service Platform Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-25O19660
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions